BSE filing, NSE: ELIXIR. Summary written from the filing by ALFA Finder's alert engine.
Elixir Capital Ltd: key numbers
- Share price
- ₹93.00
- Market cap
- ₹53.97 Cr
- Revenue (annual)
- ₹34.21 Cr
- Net profit (annual)
- ₹3.03 Cr
- P/E (TTM)
- 8.4×Sector 19.7×
- Promoter holding
- 71.17%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Elixir Capital Ltd
All →Elixir Capital Other Announcement
Elixir Capital Ltd has submitted its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with SEBI regulations.
Elixir Capital Management Change
Elixir Capital Ltd has appointed M. Parashar & Co. as its new Statutory Auditor, replacing JMT & Associates upon the completion of their tenure.
Elixir Capital Other Announcement
Elixir Capital Ltd appointed M/s. M. Parashar & Co. as statutory auditors. This follows the completion of the previous auditors' term at the 32nd Annual General Meeting.
Elixir Capital Annual General Meeting
Elixir Capital held its 32nd AGM on August 25, 2026, approving financial statements, director re-appointments, and a dividend of Rs. 1.25 per equity share.
Elixir Capital Q1 FY27 Results: Net Profit ₹6.1 Cr, Up 125.9% YoY
Elixir Capital Ltd reported revenue from operations of ₹20.4 Cr (+87.2% YoY) and net profit of ₹6.1 Cr (+125.9% YoY) for Q1 FY27.
- Key figure
- Net profit ₹6.1 Cr · +125.9% YoY
Elixir Capital Board Meeting Date
Elixir Capital Ltd scheduled a board meeting for August 13, 2026, to approve financial results for the quarter ended June 30, 2026.
Other board meeting date announcements
All →Indowind Energy Board Meeting Date
Indowind Energy scheduled a board meeting on 5 Nov 2026 to approve Q1 FY27 unaudited results. The trading window remains closed until 48 hours post-approval.
Dhunseri Ventures Board Meeting Date
Dhunseri Ventures Ltd intimated that its Board will meet on 6 November 2026, inter alia to approve Q2 FY27 results. The trading window stays closed until 8 November 2026.
CESC Board Meeting Date
CESC Ltd scheduled its Board Meeting for 5 Nov 2026 to consider Q2/H1 FY27 unaudited results. No financial figures or decisions are reported in this advance intimation.
Genpharmasec Board Meeting Date
Genpharmasec Ltd will hold a Board meeting on 03 Nov 2026. Agenda includes proposing approval of Q2/H1 FY27 unaudited results.
Hexa Tradex Board Meeting Date
Hexa Tradex scheduled its board meeting for November 5, 2026, to approve Q2 FY27 unaudited financial results. Trading window closes until 48 hours post-disclosure.
Ampvolts Board Meeting Date
Ampvolts Ltd has scheduled its Board meeting for November 6, 2026, to approve unaudited Q2/H1 FY27 results. No financial figures are disclosed in this prior intimation.